The munKNEE Psychedelic Drug Stocks Index was DOWN 3.4% in March but is still UP 1.2% YTD and the average price targets of the above stocks represent...
With uncertainty in the financial systems, many psychedelic companies are seeing their stock prices plummet. The post It’s Survival of the Fittest among...
Analysts have long expected a contraction, but when it hit it still felt sudden and strange. The post The Psychedelics Finance Crunch Seen in the SXSW...
The article News You Might Have Missed: March 13th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article The Importance of Cybin’s Next-Generation Psilocybin was originally published on Microdose. On February 28th, Cybin Inc. (NEO:CYBN, NYSE...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics ® today announced significant...
Feds: CA marijuana license fees hurt owls; WA worker protections; NC medical cannabis hits floor; NY gov visits dispensary Subscribe to receive Marijuana...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics ® today announced a streamlining...
The article Compass Pathways’ New Psilocybin For Depression Trial, Explained was originally published on Microdose. On February 17th, psychedelic medicine...
Cuts were made in areas not focused on clinical trials. The post Cybin Cuts 15% of Staff as Part of ‘Streamlining Plan’ appeared first on Green...